145 related articles for article (PubMed ID: 31088078)
1. Multiplexing Angiogenic Receptor Quantification via Quantum Dots.
Chen S; Imoukhuede PI
Anal Chem; 2019 Jun; 91(12):7603-7612. PubMed ID: 31088078
[TBL] [Abstract][Full Text] [Related]
2. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
3. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
4. VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types.
Sarkar J; Luo Y; Zhou Q; Ivakhnitskaia E; Lara D; Katz E; Sun MG; Guaiquil V; Rosenblatt M
PLoS One; 2022; 17(7):e0269818. PubMed ID: 35862373
[TBL] [Abstract][Full Text] [Related]
5. Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells.
Sarabipour S; Kinghorn K; Quigley KM; Kovacs-Kasa A; Annex BH; Bautch VL; Mac Gabhann F
PLoS Comput Biol; 2024 Feb; 20(2):e1011798. PubMed ID: 38324585
[TBL] [Abstract][Full Text] [Related]
6. Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.
Farzaneh Behelgardi M; Zahri S; Gholami Shahvir Z; Mashayekhi F; Mirzanejad L; Asghari SM
Mol Biol Rep; 2020 Mar; 47(3):2061-2071. PubMed ID: 32072404
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
Nasir A; Reising LO; Nedderman DM; Fulford AD; Uhlik MT; Benjamin LE; Schade AE; Holzer TR
Anticancer Res; 2016 Jun; 36(6):2683-96. PubMed ID: 27272777
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
Dikov MM; Ohm JE; Ray N; Tchekneva EE; Burlison J; Moghanaki D; Nadaf S; Carbone DP
J Immunol; 2005 Jan; 174(1):215-22. PubMed ID: 15611243
[TBL] [Abstract][Full Text] [Related]
9. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
10. Expression of VEGF receptors on endothelial cells in mouse skeletal muscle.
Imoukhuede PI; Popel AS
PLoS One; 2012; 7(9):e44791. PubMed ID: 22984559
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.
Bruns AF; Bao L; Walker JH; Ponnambalam S
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1193-7. PubMed ID: 19909245
[TBL] [Abstract][Full Text] [Related]
12. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
[TBL] [Abstract][Full Text] [Related]
13. Seasonal changes in immunoreactivity of vascular endothelial factor and its receptors VEGFR1 and VEGFR2 in the uterus of wild ground squirrels (Citellus dauricus Brandt).
Weng J; Li B; Sheng X; Zhang H; Hu X; Zhou J; Xu M; Weng Q; Watanabe G; Taya K
J Reprod Dev; 2012; 58(5):537-43. PubMed ID: 22673205
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas.
Baumgarten P; Brokinkel B; Zinke J; Zachskorn C; Ebel H; Albert FK; Stummer W; Plate KH; Harter PN; Hasselblatt M; Mittelbronn M
Histol Histopathol; 2013 Sep; 28(9):1157-66. PubMed ID: 23475388
[TBL] [Abstract][Full Text] [Related]
15. VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent.
Mittar S; Ulyatt C; Howell GJ; Bruns AF; Zachary I; Walker JH; Ponnambalam S
Exp Cell Res; 2009 Mar; 315(5):877-89. PubMed ID: 19162007
[TBL] [Abstract][Full Text] [Related]
16. VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study.
Stîngă AC; Mărgăritescu O; Stîngă AS; Pirici D; Ciurea R; Bunget A; Cruce M
Rom J Morphol Embryol; 2011; 52(4):1269-75. PubMed ID: 22203933
[TBL] [Abstract][Full Text] [Related]
17. Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
Holzer TR; Fulford AD; Reising LO; Nedderman DM; Zhang X; Benjamin LE; Schade AE; Nasir A
Anticancer Res; 2016 Jul; 36(7):3277-88. PubMed ID: 27354584
[TBL] [Abstract][Full Text] [Related]
18. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells.
Ulyatt C; Walker J; Ponnambalam S
Biochem Biophys Res Commun; 2011 Jan; 404(3):774-9. PubMed ID: 21168388
[TBL] [Abstract][Full Text] [Related]
20. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M
Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
